New AI Breakthrough Will Blindside Millions. Will You be One of Them?

On Feb. 13, AI expert Luke Lango will reveal a new breakthrough he calls the “AI Endgame.” In short, the final phase of the AI revolution is about to begin.

Tue, February 13 at 8:00PM ET
 
 
 
 
Here’s how to prepare.
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

A businessman ripping his shirt off to reveal an upward green arrow with the word buy on it underneath

3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?

Letting your winners run can generate portfolio returns without cutting them off by taking profits. Check out these stocks with 52-week highs.

man's hand holding wads of cash. stocks to buy. russell 2000 stocks to buy

3 Long-Term Stocks to Buy on the Dip: February 2024

The trillion-dollar market valuation club is currently dominated by the tech sector. Saudi Aramco is the sole exception. The other six members are all part...

OLK Stock. Modern Medical Research Laboratory: Two Scientists Wearing Face Masks use Microscope, Analyse Sample in Petri Dish, Talk. Advanced Scientific Lab for Medicine, Biotechnology. Blue Color. KZR stock. RSLS stock

7 Biotech Stocks Fighting America’s Deadliest Diseases

The trillion-dollar market valuation club is currently dominated by the tech sector. Saudi Aramco is the sole exception. The other six members are all part...

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks

By Paul R. La Monica, InvestorPlace Contributor
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.

3 Cannabis Stocks to Buy Before They Explode Higher

By Ian Cooper, InvestorPlace Contributor
Support for cannabis legalization reached all-time highs in 2023, creating a long list of cannabis stocks to buy today.

The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock

By Eddie Pan, InvestorPlace Financial News Writer
The New York Stock Exchange has announced that it will begin the process of delisting NVTA stock based on its "abnormally low" price.

Why Is Agrify (AGFY) Stock Up 57% Today?

By William White, InvestorPlace Writer
Agrify stock is rising higher on Tuesday as investors in AGFY celebrate a new milestone for the company with a successful installation.

NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy

By Larry Ramer, InvestorPlace Contributor
NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending. 

7 Dividend Stocks Worth Holding for the Long Haul

By Alex Sirois, InvestorPlace Contributor
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.

Why Is InVivo Therapeutics (NVIV) Stock Up 61% Today?

By William White, InvestorPlace Writer
InVivo Therapeutics stock is rising on Tuesday with heavy trading of NVIV shares as they remain volatile after a recent bankruptcy filing.

3 Fantastic Dow Stocks to Buy in February 2024

By Rich Duprey, InvestorPlace Contributor
The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars.

What’s Hot, What’s Not: China Stocks Are Out. Top Picks From 3 Other Countries

By Will Ashworth, InvestorPlace Contributor
If you are lookiing for the best inernational stocks, keep in mind that China stocks are out, but stocks from these countries are in!

3 Sleeper Stocks to Buy for the Next Bull Run: February 2024

By Muslim Farooque, InvestorPlace Contributor
Embark on a savvy investing as we uncover three sleeper stocks and chart their stellar long-term potential to perform.

3 Magnificent Stocks to Buy on the Dip: February 2024

By Josh Enomoto, InvestorPlace Contributor
While it’s a relative rarity because price generally discounts everything, that doesn’t mean you can’t find stocks to buy on dip. With thousands upon thousands...

3 Cannabis Stocks to Buy for the Next Bull Run: February 2024

By Faisal Humayun, InvestorPlace Contributor
These are the best cannabis stocks to buy as they represent undervalued names that are positioned for growth and cash flow upside.

Why Is 4D Molecular (FDMT) Stock Up 85% Today?

By Chris MacDonald, InvestorPlace Contributor
Investors in 4D Molecular Therapeutics and FDMT stock are seeing big gains today, as the stock surges 80% on positive trial results.

Why Is MorphoSys (MOR) Stock Up 50% Today?

By Chris MacDonald, InvestorPlace Contributor
News of a potential takeout bid for any company usually leads to a big surge. That's what investors are seeing today with MOR stock.

Why Is Invitae (NVTA) Stock Down 75% Today?

By Josh Enomoto, InvestorPlace Contributor
Although genetic testing specialist Invitae forwarded a compelling idea, the lack of business substance ultimately cratered NVTA stock.

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?

By Rich Duprey, InvestorPlace Contributor
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
As the new business cycle gets started, here are some biotech stocks with potential that investors should pay attention to.

The Top 3 Stocks to Watch This Week

By Stavros Tousios, InvestorPlace Contributor
There are three stocks to watch this week as they experienced significant price movements worth your attention.

Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

By William White, InvestorPlace Writer
Catalent stock is rising higher on Monday after the company announced a $16.5 billion cash acquisition deal for CTLT shares.
Load More Articles